Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations

Oncology Reports

Volumn 16, Issue 5, 2006, Pages 1041-1045

  Semczuk, Andrzej ^a   Lorenc, Anna ^b   Putowski, Lechoslaw ^a   Futyma, Konrad ^a   Bryk, Jaroslaw ^b   Miotla, Pawel ^a   Bartnik, Ewa ^b,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Mitochondrial DNA; Mutations

Indexed keywords

DNA; MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; DISEASE FREE SURVIVAL; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM SARCOMA; ENDOMETRIUM TUMOR; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MIDDLE AGED; MUTATION; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; DNA, MITOCHONDRIAL; DNA, NEOPLASM; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; SARCOMA, ENDOMETRIAL STROMAL;

EID: 39049178352     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.5.1041     Document Type: Article

References (40)

1. Zatonski W and Tyczynski J: Cancer in Poland in 2002. The Maria Sklodowska-Curie Memorial Cancer Center, National Cancer Registry, Warsaw, Poland, 2004.
2. Deligdisch L and Holinka CF: Endometrial carcinoma: two diseases? Cancer Detect Prev 10: 237-246, 1987.
3. Emons G, Fleckenstein G, Hinney B, Huschmand A and Heyl W: Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7: 227-242, 2000. (Pubitemid 32175106)
4. Sherman ME: Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13: 295-308, 2000.
5. Ronnett BM, Zaino RJ, Ellenson LH and Kurman RJ: Endometrial Carcinoma in Blaustein's Pathology of the Female Genital Tract. Kurman RJ (ed). Springer, New York, pp501-559, 2002.
6. Amant F, Moerman P, Neven P, Timmerman D, van Limbergen EV and Vergote I: Endometrial cancer. Lancet 366: 491-505, 2005. (Pubitemid 41111699)
7. INK4A pathway in endometrial carcinogenesis. Cancer Lett 203: 1-12, 2004.
8. Wallace DC: Mitochondrial diseases in man and mouse. Science 283: 1482-1488, 1999.
9. Bartnik E, Lorenc A and Mroczek K: Human mitochondria in health, disease, ageing and cancer. J Appl Genet 42: 65-71, 2001. (Pubitemid 33669657)
10. Simon DK and Johns DR: Mitochondrial disorders: clinical and genetic features. Ann Rev Med 50: 111-127, 1999. (Pubitemid 29117056)
11. Carew JS and Huang P: Mitochondrial defects in cancer. Mol Cancer 1: 9-21, 2002.
12. Copeland WC, Wachsman JT, Johnson FM and Penta JS: Mitochondrial DNA alterations in cancer. Cancer Invest 20: 557-569, 2002. (Pubitemid 34686350)
13. Czarnecka AM, Golik P and Bartnik E: Mitochondrial DNA mutations in human neoplasia. J Appl Genet 47: 67-78, 2006. (Pubitemid 43232163)
14. Liu VWS, Shi HH, Cheung ANY, Chiu PM, Leung TW, Nagley P, Wong LC and Ngan HYS: High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61: 5998-6001, 2001. (Pubitemid 32762527)
15. Pejovic T, Ladner D, Intengan M, Zheng K, Fairchild T, Dillon D, Easley S, Dillon D, Marchetti D, Schwartz P, Lele S, Costa J and Odunsi K: Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. Eur J Cancer 40: 2519-2524, 2004. (Pubitemid 39424969)
16. Wang Y, Liu VWS, Tsang PCK, Chiu PM, Cheung ANY, Khoo US, Nagley P and Ngan HYS: Microsatellite instability in mitochondrial genome of common female cancers. Int J Gynaecol Cancer 16 (Suppl. 1): S259-S266, 2006.
17. Lorenc A, Bryk J, Golik P, Kupryjanczyk J, Ostrowski J, Pronicki M, Semczuk A, Szolkowska M and Bartnik E: Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion 3: 119-124, 2003. (Pubitemid 37185477)
18. Mikuta JJ: Preoperative evaluation and staging of endometrial cancer. Cancer 76 (Suppl. 10): S2041-S2043, 1995.
19. Berek JS and Hacker NF: Practical Gynaecologic Oncology. 4th edition. Lippincott Williams and Wilkins, Philadelphia, 2005.
20. Tavassoli FA and Devilee P: Pathology and genetics of tumours of the breast and female genital organs. International Agency for Research on Cancer (IARC). IARC Press, Lyon, 2003.
21. Hayashi K: PCR-SSCP: a simple and sensitive method for detection of point mutations in the genomic DNA. PCR Methods Appl 1: 34-38, 1991.
22. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
23. Semczuk A, Skomra D, Cybulski M and Jakowicki JA: Immunohistochemical analysis of MIB-1 proliferative activity in human endometrial cancer. Correlation with clinicopathological parameters, patient outcome, retinoblastoma immunoreactivity and K-ras codon 12 point mutations. Histochem J 33: 193-200, 2001. (Pubitemid 32758584)
24. Semczuk A, Marzec B, Roessner A, Jakowicki JA, Wojcierowski J and Schneider-Stock R: Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer. Virchows Arch 441: 577-583, 2002. (Pubitemid 35435828)
25. INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features. Arch Gynecol Obstet 269: 104-110, 2004.
26. INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol 129: 589-596, 2003.
27. Semczuk A, Marzec B, Skomra D, Roessner A, Cybulski M, Rechberger T and Schneider-Stock R: Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas. Oncology 69: 317-325, 2005. (Pubitemid 41752800)
28. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J and Sidransky D: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019, 2000. (Pubitemid 30158678)
29. Zastawny TH, Dabrowska M, Jaskolski T, Klimarczyk M, Kulinski L, Koszela A, Szczesniewicz M, Sliwinska M, Witkowski P and Olinski R: Comparison of oxidative base damage in mitochondrial and nuclear DNA. Free Rad Biol Med 24: 722-725, 1998. (Pubitemid 28169558)
30. Giurgiovich AJ, Diwan BA, Olivero OA, Anderson LM, Rice JM and Poirier MC: Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure. Carcinogenesis 18: 93-96, 1997. (Pubitemid 28134621)
31. Liu VWS, Yang HJ, Wang Y, Tsang PCK, Cheung ANY, Chiu PM, Ng TY, Wong LC, Nagley P and Ngan HYS: High frequency of mitochondrial genome instability in human endometrial carcinomas. Br J Cancer 89: 679-701, 2003.
32. Liu VWS, Wang Y, Yang H-J, Tsang PCK, Ng T-Y, Wong L-C, Nagley P and Ngan HYS: Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. Hum Mutat 22: 173-174, 2003. (Pubitemid 36950816)
33. Wang Y, Liu VW, Xue WC, Tsang PC, Cheung AN and Ngan HY: The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol Oncol 98: 104-110, 2005. (Pubitemid 40826425)
34. Parrella P, Seripa D, Matera MG, Rabitti C, Rinaldi M, Mazzarelli P, Gravina C, Gallucci M, Altomare V, Flammia G, Casalino B, Benedetti-Panici PL and Fazio VM: Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett 190: 73-77, 2003. (Pubitemid 36109177)
35. Ha PK, Tong BC, Westra WH, Sanchez-Cespedes M, Parrella P, Zahurak M, Sidransky D and Califano JA: Mitochondrial C-tract alteration in premalignant lesions of the head and neck. A marker for progression and clonal proliferation. Clin Cancer Res 8: 2260-2265, 2002. (Pubitemid 34753599)
36. Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Sakata K, Endoh Y and Motoyama T: Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer 35: 316-319, 1999. (Pubitemid 29136785)
37. Khrapko K, Coller HA, Andre PC, Li XC, Hanakamp JS and Thilly WG: Mitochondrial mutational spectra in human cells and tissues. Proc Natl Acad Sci USA 94: 13789-13803, 1997.
38. Marcelino LA and Thilly WG: Mitochondrial mutagenesis in human cells and tissues. Mutat Res 434: 177-203, 1999. (Pubitemid 29352255)
39. Hiyama T, Tanaka S, Shima H, Kose K, Tuncel H, Ito M, Kitadai Y, Sumii M, Yoshihara M, Shimamoto F, Haruma K and Chayama K: Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer. Oncol Rep 10: 1837-1841, 2003.
40. Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P and Bianchi NO: Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res 60: 4231-4237, 2000. (Pubitemid 30636610)